The post Terraform Administrator Sues Jane Street Over Terra Crash appeared on BitcoinEthereumNews.com. Terraform admin sues Jane Street over alleged insider tradingThe post Terraform Administrator Sues Jane Street Over Terra Crash appeared on BitcoinEthereumNews.com. Terraform admin sues Jane Street over alleged insider trading

Terraform Administrator Sues Jane Street Over Terra Crash

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • Terraform admin sues Jane Street over alleged insider trading before Terra crash.
  • Terraform pulled $150M from Curve; Jane Street-linked wallet removed $85M minutes later.
  • Lawsuit claims Jane Street accessed Terraform’s internal liquidity info via private chats.

The bankruptcy administrator for Terraform Labs has sued Jane Street Group LLC, alleging the firm used non-public information to trade ahead of the May 2022 collapse of TerraUSD and Luna.

The complaint, filed in the US District Court for the Southern District of New York, claims Jane Street accessed internal liquidity information and used it to unwind hundreds of millions of dollars in exposure hours before the ecosystem failed.

Jane Street has denied the allegations and calls the suit an attempt to extract money, according to a report from the Wall Street Journal. 

The May 7 Liquidity Move

Terraform collapsed in May 2022 when its algorithmic stablecoin TerraUSD lost its $1 peg. Its sister token, Luna, fell to near zero within days. The combined wipeout erased roughly $40 billion in value.

On May 7, 2022, at 5:44 p.m. EST, Terraform withdrew 150 million TerraUSD from the Curve3pool liquidity pool. The withdrawal was not publicly announced at the time.

Less than 10 minutes later, a wallet linked by analysts to Jane Street withdrew 85 million TerraUSD from the same pool, according to the complaint.

The next day, Do Kwon said the 150 million withdrawal was meant to move liquidity to a new pool. However, the timing of the shift was not public when the trades occurred.

The lawsuit alleges Jane Street had advance insight into these internal decisions and positioned itself around them. As per the report, the plaintiff said that Terraform removed liquidity, and market depth weakened as Jane Street withdrew shortly after, accelerating peg instability.

Alleged Back-Channel Communications

The complaint states that Jane Street began a deeper engagement with Terraform in February 2022. Bryce Pratt, a former Terraform intern who joined Jane Street, allegedly set up direct communication lines with Terraform staff.

A private group chat titled “Bryce’s Secret” allegedly included Terraform employees and was used to share information. The administrator claims these communications became a source of material non-public information.

The lawsuit also alleges Jane Street discussed potential investment opportunities while gaining insight into the internal liquidity strategy.

On May 9, with TerraUSD already below peg but not fully collapsed, Pratt reportedly set up a group message with Kwon and others to discuss bidding on Bitcoin or Luna. The market was already under stress.

The case claims that Jane Street had continued access to sensitive information during the crisis window.

Related: Jump Trading Hit With $4B Lawsuit Linked to Terraform Collapse

Disclaimer: The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.

Source: https://coinedition.com/terraform-administrator-sues-jane-street-over-terra-crash/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09